Lim, J., Kim, Y. N., Oh, B. B., Hwang, J., Jung, Y., Kim, S., Lee, S., Lee, J. S., Ju, Y. S., Lee, J. (2026). Whole-genome HRD phenotyping as a predictor of PARP inhibitor benefit in first-line maintenance high-grade serous ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17608